Are Options Traders Bullish on ANAB?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About ANAB

AnaptysBio is a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation. The companys proprietary anti-inflammatory pipeline includes its anti-IL-33 antibody (ANB020) for the treatment of moderate-to-severe adult atopic dermatitis, severe adult peanut allergy and severe adult eosinophilic asthma; its anti-IL-36R antibody (ANB019) for the treatment of rare inflammatory diseases, including generalized pustular psoriasis and palmo-plantar pustular psoriasis; and a portfolio of checkpoint receptor agonist antibodies for the treatment of certain autoimmune diseases where immune checkpoint receptors are insufficiently activated and have demonstrated efficacy in an animal model of graft-versus-host disease. AnaptysBios antibody pipeline has been developed using its proprietary somatic hypermutation (SHM) platform, which uses in vitro SHM for antibody discovery and is designed to replicate key features of the human immune system to overcome the limitations of competing antibody discovery technologies. AnaptysBio has also developed multiple therapeutic antibodies in an immuno-oncology partnership with TESARO and an inflammation partnership with Celgene, including an anti-PD-1 antagonist antibody (TSR-042) and an anti-TIM-3 antagonist antibody (TSR-022), which are currently under clinical development with TESARO, and an anti-PD-1 checkpoint agonist antibody (CC-90006) currently in the clinic with Celgene.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ANAB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 250.8 M 2.50848E+08 234 234 0.09% 0.000942073 534 K 533644
EQWS Invesco Russell 2000 Equal Weight ETF 19.8 M 1.98E+07 1,952 1952 0.03% 0.00028 6 K 5698
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 356 356 0.03% 0.00031142 477 K 477163
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.01514E+09 223 223 0.26% 0.0026 21.4 M 2.13795E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.7 B 1.66582E+10 3,384 3384 0.01% 0.0001 1.0 M 1045050
IWM iShares Russell 2000 ETF 41.0 B 4.10473E+10 2,023 2023 0.08% 0.0008 33.0 M 3.29771E+07
IWO iShares Russell 2000 Growth ETF 8.7 B 8.71565E+09 1,249 1249 0.15% 0.0015 13.7 M 1.36998E+07
IWV iShares Russell 3000 ETF 9.5 B 9.45892E+09 2,989 2989 0.01% 0.0001 561 K 561243
JKJ iShares Morningstar Small-Cap ETF 215.7 M 2.15735E+08 278 278 0.25% 0.0025 558 K 557956
LABU Direxion Daily S&P Biotech Bull 3X Shares 588.0 M 5.88013E+08 129 129 0.01% 6.29244E-05 149 K 149283
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,013 1013 0.02% 0.000183168 326 K 325584
SBIO ALPS Medical Breakthroughs ETF 177.3 M 1.77255E+08 72 72 2.39% 0.0239 4.3 M 4296551
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.36018E+09 2,015 2015 0.01% 0.000108 145 K 144881
UBIO Proshares UltraPro Nasdaq Biotechnology 32.6 M 3.26377E+07 228 228 0.06% 0.000585547 64 K 63847
URTY ProShares UltraPro Russell2000 104.8 M 1.04822E+08 2,034 2034 0.01% 0.000137591 51 K 50779
UWM ProShares Ultra Russell2000 166.3 M 1.66292E+08 2,034 2034 0.03% 0.000277853 103 K 102553
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.0 B 3.95478E+09 122 122 1.28% 0.0128374 52.4 M 5.239256E+07

Wait, Before You Leave...